What is Gleevec?

Apr 26, 2023 Source: Cainiu Health

Dr. Pan Yongyuan

Introduction

Gleevec is a targeted therapy drug, with the generic name imatinib mesylate used clinically. It is indicated for the treatment of chronic myeloid leukemia and can also be used for malignant gastrointestinal stromal tumors that have metastasized. Patients generally take the medication with food to reduce the risk of gastrointestinal disturbances. When taken as prescribed, the drug can block the gene's signal transduction pathway and help control disease progression.

Glennon is a targeted therapy drug, with the generic name imatinib mesylate used in clinical practice. Specific details are as follows:

Imatinib mesylate is a Western medicine available in various clinical formulations such as capsules and tablets. It is an antitumor agent indicated for the treatment of chronic myeloid leukemia and for malignant gastrointestinal stromal tumors that have metastasized. Patients usually take the medication with meals to reduce the risk of gastrointestinal disturbances. When taken according to medical instructions, it can block gene signal transduction pathways and help control disease progression. Regular follow-up examinations are required during treatment, and any adverse drug reactions should be promptly reported to the attending physician.

In addition to medication, patients should maintain proper daily dietary control, ensure balanced nutrition, and avoid spicy or irritating foods.

View All

What should I do if my eyes swell after taking Gleevec?

Gleevec, also known as imatinib mesylate capsules, may cause eyelid swelling in some patients. This could be an adverse reaction to the medication. The condition can be improved by temporarily discontinuing the drug, applying warm compresses, or switching to another medication. During treatment, maintaining a positive mindset and a healthy lifestyle is beneficial for improving the condition.

View Full Answer

Is Gleevec a chemotherapy drug or a targeted therapy drug?

Gleevec, also known as imatinib mesylate tablets, is a type of targeted therapy drug. Imatinib mesylate tablets are primarily used to treat certain types of cancers such as chronic myeloid leukemia and gastrointestinal stromal tumors. Unlike traditional chemotherapy drugs, targeted therapy drugs achieve cancer treatment by specifically interfering with the growth and division processes of cancer cells.